| ID | Name | CAS | Data |
log10WS |
| 82-247-7 |
1-ETHYL-3-CARBOXY-6-FLUORO-7-(PIPERAZINYL-1)-QUINOLIN-4(1H)-ONE
|
|
5 | -2.91 |
| 84-681-3 |
(2E,8E)-9-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one
|
88660-10-0 |
5 | -5.11 |
| 84-686-8 |
Estra-1,3,5,7,9-pentaen-17-one, 3-[(trimethylsilyl)oxy]-
|
|
5 | -5.01 |
| 84-741-6 |
(E)-9-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one
|
30505-89-6 |
5 | -4.68 |
| 84-951-3 |
7-Methoxy-8-(3-methyl-2-oxobutyl)-2H-chromen-2-one
|
1088-17-1 |
5 | -3.05 |
| 85-660-5 |
Acetamide, N-[4-[[(5-methyl-3-isoxazolyl)amino]sulfonyl]phenyl]-
|
21312-10-7 |
5 | -2.78 |
| 85-727-1 |
8-Azabicyclo[3.2.1]octane-3,6-diol, 8-methyl-, 3-acetate
|
54725-46-1 |
5 | -0.30 |
| 90-204-5 |
4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-
|
3301-49-3 |
5 | -4.18 |
| 93-562-5 |
Coumarin, 3-formyl-4-methyl-7-(N,N-diethyl amino)-
|
142730-48-1 |
5 | -3.93 |
| 93-575-1 |
(S)-8-((3,3-Dimethyloxiran-2-yl)methyl)-7-methoxy-2H-chromen-2-one
|
23971-42-8 |
5 | -2.67 |
| 93-596-8 |
1,3-Dihydroxy-2-methoxy-10-methylacridin-9(10H)-one
|
16584-46-6 |
5 | -3.33 |
| 93-696-7 |
8-(2,3-Dihydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one
|
5673-37-0 |
5 | -2.00 |
| 94-016-0 |
3H-Pyrimidin-4-one, 2,3-pentamethyleno-5,6-trimethyleno
|
|
5 | -1.79 |
| 96-289-6 |
(2E,4E,8E)-9-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one
|
107584-38-3 |
5 | -4.87 |
| 97-156-2 |
6-Chloro-N,N'-(1-methylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -4.81 |
| 97-269-7 |
17-ACETOXY-6-CHLORO-4,6-PREGNADIENE-3,20-DIONE
|
|
5 | -5.38 |
| 97-341-6 |
(E)-11-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)undec-10-en-1-one
|
|
5 | -5.39 |
| 97-777-3 |
(E)-7-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one
|
30505-92-1 |
5 | -3.92 |
| 97-883-5 |
(E)-9-(Benzo[d][1,3]dioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one
|
62510-52-5 |
5 | -4.43 |
| 97-944-7 |
(2E,4E,8E)-9-(Benzo[d][1,3]dioxol-5-yl)-1-(pyrrolidin-1-yl)nona-2,4,8-trien-1-one
|
117137-68-5 |
5 | -4.64 |
| 99-094-9 |
(2E,4E,10E)-11-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)undeca-2,4,10-trien-1-one
|
88660-11-1 |
5 | -5.57 |
| 99-126-3 |
(2E,10E)-11-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)undeca-2,10-dien-1-one
|
807618-21-9 |
5 | -5.78 |
| 100-552-7 |
1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutanone
|
|
5 | -4.10 |
| 100-935-2 |
2-N-tert-butyl-4-N-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
5 | -3.59 |
| 101-942-3 |
4-amino-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
|
|
5 | -2.21 |
| 104-659-5 |
4-amino-N-(4-methyl-1,3-thiazol-2-yl)benzenesulfonamide
|
|
5 | -2.91 |
| 108-102-8 |
2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl acetate
|
|
5 | -4.70 |
| 109-076-7 |
4-amino-N-(5-propan-2-yl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
|
|
5 | -3.41 |
| 112-114-0 |
(17-acetyl-6-chloro-10,13-dimethyl-3-oxo-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-17-yl) acetate
|
|
5 | -4.95 |
| 113-123-9 |
9(10H)-Acridinone, 1-hydroxy-2,3,4-trimethoxy-10-methyl-
|
7008-68-6 |
5 | -3.07 |
| 113-697-3 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1,3-trimethyl-butyl)-amine
|
|
5 | -5.21 |
| 114-139-1 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1-dimethyl-propyl)-amine
|
|
5 | -4.49 |
| 114-491-0 |
8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-methylcarbamate(ester),endo-
|
67139-52-0 |
5 | -0.55 |
| 114-611-6 |
2H-1-Benzopyran-2-one, 7-(ethylamino)-4,6-dimethyl-
|
|
5 | -3.50 |
| 115-065-2 |
6-Chloro-N,N'-(1,1,3-trimethylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -6.68 |
| 115-132-7 |
2-([(Dimethylamino)methylene]amino)-3-(3-chloro-4-methyloxy-phenyl)propanoic acid, methyl ester
|
|
5 | -2.91 |
| 115-468-5 |
6-Chloro-N,N'-(1,2,2-trimethylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -6.09 |
| 115-909-5 |
6-Chloro-N,N'-(1,3,3-trimethylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -6.76 |
| 116-006-6 |
6-Chloro-N,N'-(1,1-dimethylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -6.22 |
| 116-086-8 |
6-Chloro-N,N'-(1,1-dimethylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -5.70 |
| 116-393-7 |
6-Chloro-N,N'-(1-methylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -5.39 |
| 117-307-1 |
1-Hydroxy-3,4-dimethoxy-10-methylacridin-9(10H)-one
|
96935-29-4 |
5 | -3.47 |
| 118-085-7 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3,5-trimethyl-5-phenyl-
|
|
5 | -2.38 |
| 118-733-7 |
Barbituric acid, 5-(1-cyclohexen-1-yl)-5-ethyl-1,3-dimethyl-
|
891-90-7 |
5 | -2.68 |
| 119-363-7 |
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-
|
29331-92-8 |
5 | -2.61 |
| 119-632-8 |
3,5-Dimethyl-5-(3-oxocyclohex-1-enyl)-hexahydropyrimidin-2,4,6-trione
|
|
5 | -2.15 |
| 120-088-1 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1-ethyl-3,5-dimethyl-
|
55044-42-3 |
5 | -2.91 |
| 120-569-7 |
6-Chloro-N-sec-butyl-N'-acetyl-1,3,5-triazine-2,4-diamine
|
|
5 | -3.72 |
| 120-972-9 |
4-(5-ETHYLQUINUCLIDINE-2-CARBONYL)-1,2-DIHYDRO-2-OXOQUINOLINE
|
|
5 | -3.28 |
| 121-553-3 |
4-ISOPROPYL-2,3-DIMETHYL-1-PHENYL-3-PYRAZOLIN-5-ONE
|
|
5 | -1.33 |
| 122-532-5 |
6-Chloro-N,N'-(1,2-dimethylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -5.28 |
| 122-669-4 |
Pregn-5-en-20-one, 3,21-bis[(trimethylsilyl)oxy]-, (3.beta.)-
|
|
5 | -5.40 |
| 122-680-1 |
8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-methylcarbamate(ester),exo-
|
67139-53-1 |
5 | -0.55 |
| 122-829-6 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-(2-methylpropyl)-5-(2-propenyl)-
|
55045-04-0 |
5 | -2.20 |
| 122-995-2 |
2,4-bis(1,3-dimethylbutyl-amino)-6-chloro-s-triazine
|
|
5 | -5.98 |
| 123-506-3 |
17«beta»-Estradiol, 3,17-di(dimethyl-tert-butylsilyl)ether
|
57711-41-8 |
5 | -7.27 |
| 128-367-3 |
N,N-dimethyl-3-[1-(phenylmethyl)cycloheptyl]oxypropan-1-amine
|
|
5 | -1.62 |
| 10-422-1 |
7-Chloro-N-(3-[(diethylamino)methyl]-4-[(trimethylsilyl)oxy]phenyl)-N-(trimethylsilyl)quinolin-4-amine
|
|
4 | -5.69 |
| 12-207-8 |
2,6-Pyridinedicarboxylic acid, isobutyl 3-(2-methoxyethyl)nonyl ester
|
|
4 | -5.39 |
| 12-585-9 |
O-methyl o,o-bis(2,4,5-trichlorophenyl) thiophosphate
|
56201-37-7 |
4 | -8.80 |
| 13-737-9 |
Benzoic acid, 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]-, 1-methylethyl ester
|
|
4 | [-4.19; -4.19] |
| 13-841-3 |
9H-purine, 2-amino-6-methyl-9-beta-d-ribofuranosyl-
|
|
4 | -1.79 |
| 14-075-3 |
9H-purine-6(1h)-thione, 1-methyl-9-beta-d-ribofuranosyl-
|
|
4 | -1.59 |
| 14-894-4 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTMS
|
|
4 | -6.03 |
| 15-122-9 |
3-«alpha»,4-«xi»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | -6.95 |
| 15-718-8 |
5-«alpha»-Cholanoic acid, 3-«alpha»-12-«beta»-dihydroxy, methyl ester, TMS
|
|
4 | -6.65 |
| 15-885-3 |
7-Oxo-3«alpha»-hydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | -5.61 |
| 16-602-5 |
3-«alpha»,6-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | -6.52 |
| 16-851-9 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylbutyl)-
|
28239-47-6 |
4 | -2.35 |
| 16-934-7 |
5«beta»-cholanoate,3«alpha»,7«alpha»-dihydroxy, methyl ester-trimethylsilyl ether
|
|
4 | -6.52 |
| 17-776-2 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (20-O)-TBDMSi
|
|
4 | -6.18 |
| 17-810-3 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | -5.29 |
| 18-493-5 |
2-Hydroxy-3-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | -4.60 |
| 20-651-6 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»)-
|
7337-91-9 |
4 | -5.40 |
| 21-375-2 |
2-Naphthalenol, 1-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]-
|
85-83-6 |
4 | -6.00 |
| 22-284-2 |
3«alpha»,7«alpha»-Dihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
4 | -7.53 |
| 22-537-1 |
3«alpha»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | -6.77 |
| 22-711-7 |
Androst-5-en-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»)-
|
3747-91-9 |
4 | -5.04 |
| 22-837-8 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«beta»,5«alpha»)-
|
57711-44-1 |
4 | -5.93 |
| 23-353-4 |
6-Chloro-N,N'-(cyclopentyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | -5.55 |
| 23-363-3 |
21-Hydroxypregn-4-en-3,20-dione, 20,21-methylboronate
|
|
4 | -5.13 |
| 23-577-6 |
5«alpha»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-92-4 |
4 | -5.53 |
| 23-731-4 |
5-Pregnen-3«beta»-ol-20-one, tert-butyldimethylsilyl ether
|
|
4 | -5.78 |
| 23-873-7 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
4867-14-5 |
4 | -5.40 |
| 24-360-5 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
1218-51-5 |
4 | -1.65 |
| 24-406-4 |
1-Alpha-2-methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline
|
10421-76-8 |
4 | -3.21 |
| 25-279-5 |
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-
|
|
4 | -2.45 |
| 25-709-7 |
Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione
|
|
4 | -1.83 |
| 25-777-2 |
N-tert-Butyl-6-chlor-[1,3,5]triazin-2,4-diamine
|
|
4 | -3.91 |
| 26-843-7 |
20«beta»,21-Dihydroxypregn-4-en-3-one, 20,21-bis-TMS
|
|
4 | -5.56 |
| 27-739-2 |
1-«beta»,3-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | -6.85 |
| 28-354-8 |
3«beta»-Hydroxy-7«alpha»-methoxycholanic acid, methyl ester, TMS
|
|
4 | -5.91 |
| 29-039-7 |
3«beta»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | -6.77 |
| 30-482-3 |
3-«beta»-Hydroxy-D-homo-5-androsten-17-one, TMS
|
|
4 | -5.10 |
| 31-293-2 |
3«alpha»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | -6.95 |
| 31-901-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate
|
|
4 | -4.64 |
| 32-154-5 |
11B-Hydroxyandrosterone (5A-Androstan-3A,11B-diol-17-one), TMS
|
|
4 | -5.20 |
| 32-347-1 |
4-(3-Methyl-2-oxobutoxy)-7H-furo[3,2-g][1]benzopyran-7-one
|
5058-15-1 |
4 | -3.85 |
| 32-486-7 |
4-Androsten-17«alpha»-ol-3-one (epitestosterone), MO-TMS
|
|
4 | -5.26 |
| 32-504-6 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-E][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«beta»)]-
|
489-72-5 |
4 | -1.65 |
|
« Previous Results
Next Results »
|